Ocular Therapeutix (OCUL) Stock: Buy, Sell, or Hold?
$6.61
-0.24 (-3.50%)
▼
5d:
-3.08%
30d:
-12.57%
90d:
-35.39%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (90%)
Quality Score
65/100
Position
SLIGHTLY LOW
30-Day Fair Range
$6.57 – $7.32
Position: SLIGHTLY LOW
Forward P/E & Valuation
-4.1x
Next 12M consensus est.
Wall Street Target
$25.45
+285.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.05 / $7.54
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: OCUL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $6.61, which is considered slightly low relative to its 30-day fair value range of $6.57 to $7.32.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $6.05, while resistance sits at $7.54. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: OCUL scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.45 (+285.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $6.05, while resistance sits at $7.54. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: OCUL scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.45 (+285.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.57 -
$7.32
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$6.57 -
$7.32
Current vs Trading Range
SLIGHTLY LOW
Support Level
$6.05
Resistance Level
$7.54
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 285.1% below Wall St target ($25.45)
- BULLISH: Bottoming setup score 65/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-4.14
Wall Street Target
$25.45
(+285.1%)
Revenue Growth (YoY)
-11.5%
Share OCUL Analysis
Share this live OCUL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OCUL)
Bullish
5 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Ocular Therapeutix ($OCUL) reported landmark Phase 3 results for AXPAXLI in wet AMD, demonstrating durable vision maintenance and preparing for NDA submission in Q4 2026. The company's strong cash position supports commercialization efforts.
Key Retail Themes:
Positive Phase 3 results
NDA submission
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:18 AM ET
Data refreshes hourly during market hours. Next update: 10:18 AM
Data refreshes hourly during market hours. Next update: 10:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 43 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 36 SELL |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$35 | 57 HOLD |
|
NKTR
Nektar Therapeutics |
STRONG BUY
15 analysts |
$133 | 66 BUY |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OCUL Research Pages
